Literature DB >> 12362029

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.

L Van Maldergem1, J Magré, T E Khallouf, T Gedde-Dahl, M Delépine, O Trygstad, E Seemanova, T Stephenson, C S Albott, F Bonnici, V R Panz, J L Medina, P Bogalho, F Huet, S Savasta, A Verloes, J J Robert, H Loret, M De Kerdanet, N Tubiana-Rufi, A Mégarbané, J Maassen, M Polak, D Lacombe, C R Kahn, E L Silveira, F H D'Abronzo, F Grigorescu, M Lathrop, J Capeau, S O'Rahilly.   

Abstract

Generalised lipodystrophy of the Berardinelli-Seip type (BSCL) is a rare autosomal recessive human disorder with severe adverse metabolic consequences. A gene on chromosome 9 (BSCL1) has recently been identified, predominantly in African-American families. More recently, mutations in a previously undescribed gene of unknown function (BSCL2) on chromosome 11, termed seipin, have been found to be responsible for this disorder in a number of European and Middle Eastern families. We have studied the genotype/phenotype relationships in 70 affected subjects from 44 apparently unrelated pedigrees of diverse ethnic origin. In all subjects, hepatic dysfunction, hyperlipidaemia, diabetes mellitus, and hypertrophic cardiomyopathy were significant contributors to morbidity with no clear differences in their prevalence between subjects with BSCL1 or BSCL2 and those with evidence against cosegregation with either chromosome 9 or 11 (designated BSCLX). BSCL2 appears to be a more severe disorder than BSCL1 with a higher incidence of premature death and a lower prevalence of partial and/or delayed onset of lipodystrophy. Notably, subjects with BSCL2 had a significantly higher prevalence of intellectual impairment than those with BSCL1 or BSCLX (p<0.0001, OR 17.0, CI 3.6 to 79.0). The higher prevalence of intellectual impairment and the increased risk of premature death in BSCL2 compared to BSCL1 emphasise the importance of molecular diagnosis of this syndrome and have clear implications for genetic counselling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362029      PMCID: PMC1734991          DOI: 10.1136/jmg.39.10.722

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

Review 2.  Genetically defined forms of diabetes in children.

Authors:  S I Taylor; E Arioglu
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

3.  LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

Authors:  S Shackleton; D J Lloyd; S N Jackson; R Evans; M F Niermeijer; B M Singh; H Schmidt; G Brabant; S Kumar; P N Durrington; S Gregory; S O'Rahilly; R C Trembath
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

4.  An undiagnosed endocrinometabolic syndrome: report of 2 cases.

Authors:  W BERARDINELLI
Journal:  J Clin Endocrinol Metab       Date:  1954-02       Impact factor: 5.958

5.  Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

Authors:  J Magré; M Delépine; E Khallouf; T Gedde-Dahl; L Van Maldergem; E Sobel; J Papp; M Meier; A Mégarbané; A Bachy; A Verloes; F H d'Abronzo; E Seemanova; R Assan; N Baudic; C Bourut; P Czernichow; F Huet; F Grigorescu; M de Kerdanet; D Lacombe; P Labrune; M Lanza; H Loret; F Matsuda; J Navarro; A Nivelon-Chevalier; M Polak; J J Robert; P Tric; N Tubiana-Rufi; C Vigouroux; J Weissenbach; S Savasta; J A Maassen; O Trygstad; P Bogalho; P Freitas; J L Medina; F Bonnicci; B I Joffe; G Loyson; V R Panz; F J Raal; S O'Rahilly; T Stephenson; C R Kahn; M Lathrop; J Capeau
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

6.  Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.

Authors:  R A Speckman; A Garg; F Du; L Bennett; R Veile; E Arioglu; S I Taylor; M Lovett; A M Bowcock
Journal:  Am J Hum Genet       Date:  2000-04       Impact factor: 11.025

Review 7.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

8.  Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.

Authors:  C Vigouroux; J Magré; M C Vantyghem; C Bourut; O Lascols; S Shackleton; D J Lloyd; B Guerci; G Padova; P Valensi; A Grimaldi; R Piquemal; P Touraine; R C Trembath; J Capeau
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

9.  A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.

Authors:  A Garg; R Wilson; R Barnes; E Arioglu; Z Zaidi; F Gurakan; N Kocak; S O'Rahilly; S I Taylor; S B Patel; A M Bowcock
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

Review 10.  The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases.

Authors:  L C Mounkes; B Burke; C L Stewart
Journal:  Trends Cardiovasc Med       Date:  2001-10       Impact factor: 6.677

View more
  79 in total

1.  Berardinelli-Seip lipodystrophy.

Authors:  Yuko Kobashi; Amy Schoenbaum; Robert P Hasserjian; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2007-06-07       Impact factor: 2.199

Review 2.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 3.  Lipodystrophy syndromes.

Authors:  Pedro Herranz; Raul de Lucas; Luis Pérez-España; Matias Mayor
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

4.  Functional magnetic resonance imaging analysis of food-related brain activity in patients with lipodystrophy undergoing leptin replacement therapy.

Authors:  Daisuke Aotani; Ken Ebihara; Nobukatsu Sawamoto; Toru Kusakabe; Megumi Aizawa-Abe; Sachiko Kataoka; Takeru Sakai; Hitomi Iogawa; Chihiro Ebihara; Junji Fujikura; Kiminori Hosoda; Hidenao Fukuyama; Kazuwa Nakao
Journal:  J Clin Endocrinol Metab       Date:  2012-08-07       Impact factor: 5.958

5.  The clinical approach to the detection of lipodystrophy - an AACE consensus statement.

Authors:  Yehuda Handelsman; Elif A Oral; Zachary T Bloomgarden; Rebecca J Brown; Jean L Chan; Daniel Einhorn; Alan J Garber; Abhimanyu Garg; W Timothy Garvey; George Grunberger; Robert R Henry; Norman Lavin; Carmen D Tapiador; Christian Weyer
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

6.  A Patient with Congenital Generalized Lipodystrophy Due To a Novel Mutation in BSCL2: Indications for Secondary Mitochondrial Dysfunction.

Authors:  Ellen H Jeninga; Monique de Vroede; Nicole Hamers; Johannes M P J Breur; Nanda M Verhoeven-Duif; Ruud Berger; Eric Kalkhoven
Journal:  JIMD Rep       Date:  2011-11-04

Review 7.  Genetics of Lipodystrophy.

Authors:  Marissa Lightbourne; Rebecca J Brown
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-22       Impact factor: 4.741

Review 8.  Seipin: from human disease to molecular mechanism.

Authors:  Bethany R Cartwright; Joel M Goodman
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

9.  Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy.

Authors:  Víctor A Cortés; David E Curtis; Suja Sukumaran; Xinli Shao; Vinay Parameswara; Shirya Rashid; Amy R Smith; Jimin Ren; Victoria Esser; Robert E Hammer; Anil K Agarwal; Jay D Horton; Abhimanyu Garg
Journal:  Cell Metab       Date:  2009-02       Impact factor: 27.287

10.  Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene.

Authors:  H U Shirwalkar; Z M Patel; J Magre; P Hilbert; L Van Maldergem; R R Mukhopadhyay; A Maitra
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.